36 in healthy participants
Patients with a history of gastrointestinal conditions such as acid reflux, irritable bowel syndrome, or gastroparesis should be especially cautious when starting GLP-1 medications
However, darker skin types must use it with caution, since skin lightening can occur
Cognitive impairment or dementia in post-acute COVID-19 syndrome
J., & Amrein, R
00:00:12 Narrator On this episode, associate editor and clinical pharmacist, Vicki Danaher, shares practical guidance on how Orforglopron, the second oral GLP-1 agonist for weight loss, stacks up against oral semaglutide in terms of dosing, efficacy, safety, cost, and more in an excerpt from our popular Pharmacy Essential Updates webinar series